Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis. by Ballabio, E, Milne, T

MEASUREMENT OF MICRORNA EXPRESSION LEVELS BY QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION IS A USEFUL TOOL TO PREDICT OUTCOME IN PATIENTS WITH B CELL CHRONIC LYMPHOCYTIC LEUKAE... by Schuh, A, Ballabio, E, Gooding, S, Dyar, O, Jones, M, Lawrie, C

DOP-PCR products amplified from genomic DNA can be used reliably in whole genome array CGH studie for the detection of delections and duplications in leukaemia by Wilson, K, Ballabio, E, Regan, R, Hedman, A, Jarrett, R, Knight, S, Tosi, S

Comparison of Choi and Hans' algorithms by immunohistochemistry and quantitative reverse transcriptase-PCR - letter. by Ballabio, E, Chi, J, Roncador, G, Banham, A, Hatton, C, Lawrie, C

Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute m... by Tosi, S, Ballabio, E, Teigler-Schlegel, A, Boultwood, J, Bruch, J, Harbott, J

INVESTIGATION OF THE MOLECULAR BASIS OF LENALIDOMIDE TREATMENT IN LYMPHOMA CELL LINES by Ballabio, E, Fernandez-Santamaria, C, Tramonti, D, Chen, X, Wainscoat, J, Boultwood, J, Hatton, C, Lawrie, C

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. by Lawrie, C, Chi, J, Taylor, S, Tramonti, D, Ballabio, E, Palazzo, S, Saunders, N, Pezzella, F, Boultwood, J, Wainscoat, J, Hatton, C

MLL-AF4 binds directly to a BCL-2 specific enhancer and modulates H3K27 acetylation. by Godfrey, L, Kerry, J, Thorne, R, Repapi, E, Davies, J, Tapia, M, Ballabio, E, Hughes, J, Geng, H, Konopleva, M, Milne, T

MicroRNA expression in chronic lymphocytic leukaemia. by Lawrie, C, Ballabio, E, Dyar, O, Jones, M, Ventura, R, Chi, J, Tramonti, D, Gooding, S, Boultwood, J, Wainscoat, J, Hatton, C, Schuh, A

Rehabilitation technology : Strategies for The European Union : Proceedings of The 1st TIDE Congress, 6-7 April 1993, Brussels/ by TIDE Congress (1st : 1993 : Brussels, Belgium) 479968, Ballabio, E., editor 425020, Placencia-Porrero, I., editor 425022, De La Bellacasa, R. Puig, editor 425030

RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. by Wilkinson, A, Ballabio, E, Geng, H, North, P, Tapia, M, Kerry, J, Biswas, D, Roeder, R, Allis, C, Melnick, A, de Bruijn, M, Milne, T

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. by Chi, J, Ballabio, E, Chen, X, Kušec, R, Taylor, S, Hay, D, Tramonti, D, Saunders, N, Littlewood, T, Pezzella, F, Boultwood, J, Wainscoat, J, Hatton, C, Lawrie, C

Genomic imbalances are confined to non-proliferating cells in paediatric patients with acute myeloid leukaemia and a normal or incomplete karyotype. by Ballabio, E, Regan, R, Garimberti, E, Harbott, J, Bradtke, J, Teigler-Schlegel, A, Biondi, A, Cazzaniga, G, Giudici, G, Wainscoat, J, Boultwood, J, Bridger, J, Knight, S, Tosi, S

RUNX1 Is a Key Target in t(4;11) Leukemias that Contributes to Gene Activation through an AF4-MLL Complex Interaction by Wilkinson, A, Ballabio, E, Geng, H, Geng, H, Geng, H, North, P, Tapia, M, Kerry, J, Biswas, D, Roeder, R, Allis, C, Melnick, A, Melnick, A, de Bruijn, M, Milne, T

MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. by Kerry, J, Godfrey, L, Repapi, E, Tapia, M, Blackledge, N, Ma, H, Ballabio, E, O'Byrne, S, Ponthan, F, Heidenreich, O, Roy, A, Roberts, I, Konopleva, M, Klose, R, Geng, H, Milne, T

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. by Ballabio, E, Mitchell, T, van Kester, MS, Taylor, S, Dunlop, H, Chi, J, Tosi, I, Vermeer, M, Tramonti, D, Saunders, N, Boultwood, J, Wainscoat, J, Pezzella, F, Whittaker, S, Tensen, C, Hatton, C, Lawrie, C

The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia by Numata, A, Kwok, HS, Kawasaki, A, Li, J, Zhou, Q-L, Kerry, J, Benoukraf, T, Bararia, D, Li, F, Ballabio, E, Tapia, M, Deshpande, AJ, Welner, RS, Delwel, R, Yang, H, Milne, TA, Taneja, R, Tenen, DG

Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation by Crump, NT, Hadjinicolaou, AV, Xia, M, Walsby-Tickle, J, Gileadi, U, Chen, J-L, Setshedi, M, Olsen, LR, Lau, I-J, Godfrey, L, Quek, L, Yu, Z, Ballabio, E, Barnkob, MB, Napolitani, G, Salio, M, Koohy, H, Kessler, BM, Taylor, S, Vyas, P, McCullagh, JSO, Milne, TA, Cerundolo, V

MLL-rearranged acute lymphoblastic leukemias activate BCL-2 through H3K79 methylation and are sensitive to the BCL-2-specific antagonist ABT-199 by Benito, J, Godfrey, L, Kojima, K, Hogdal, L, Wunderlich, M, Geng, H, Marzo, I, Harutyunyan, K, Golfman, L, North, P, Kerry, J, Ballabio, E, Chonghaile, T, Gonzalo, O, Qiu, Y, Jeremias, I, Debose, L, O'Brien, E, Ma, H, Zhou, P, Jacamo, R, Park, E, Coombes, K, Zhang, N, Thomas, D, O'Brien, S, Kantarjian, H, Leverson, J, Kornblau, S, Andreeff, M, Müschen, M, Zweidler-McKay, P, Mulloy, J, Letai, A, Milne, T, Konopleva, M